感染性休克的液体复苏参考教学课件.ppt
- 【下载声明】
1. 本站全部试题类文档,若标题没写含答案,则无答案;标题注明含答案的文档,主观题也可能无答案。请谨慎下单,一旦售出,不予退换。
2. 本站全部PPT文档均不含视频和音频,PPT中出现的音频或视频标识(或文字)仅表示流程,实际无音频或视频文件。请谨慎下单,一旦售出,不予退换。
3. 本页资料《感染性休克的液体复苏参考教学课件.ppt》由用户(晟晟文业)主动上传,其收益全归该用户。163文库仅提供信息存储空间,仅对该用户上传内容的表现方式做保护处理,对上传内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!
4. 请根据预览情况,自愿下载本文。本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
5. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007及以上版本和PDF阅读器,压缩文件请下载最新的WinRAR软件解压。
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 感染性 休克 液体 复苏 参考 教学 课件
- 资源描述:
-
1、感染性休克的液体复苏1 感染性休克的液体复苏 补什么?补多少?补多快?2 2022-12-4Fluid resuscitation of septic shock 2001 EGDT 2004 initial guidelines 2008 updated version guidelines 2010 severe sepsis bundles3 2022-12-4Fluid resuscitation of septic shock 2001 EGDT 2004 initial guidelines 2008 updated version guidelines 2010 severe s
2、epsis bundles 2012 updated Guidelines4 2022-12-4Emanuel Rivers et al.N Engl J Med 2001;345:1368-77In-hospital mortality was 30.5 percent in the group assigned to early goal-directed therapy,as compared with 46.5 percent in the group assigned to standard therapy(P=0.009).5 2022-12-4Emanuel Rivers et
3、al.N Engl J Med 2001;345:1368-776 2022-12-4Emanuel Rivers et al.N Engl J Med 2001;345:1368-777 2022-12-4Emanuel Rivers et al.N Engl J Med 2001;345:1368-778 2022-12-4R.Phillip Dellinger et al.Crit Care Med.2008;36(1):296-327.9 2022-12-4R.Phillip Dellinger et al.Crit Care Med.2008;36(1):296-327.10 202
4、2-12-4Fluid therapy Fluid-resuscitate using crystalloids or colloids.(1B)Target a CVP of 8mmHg(12mmHg if mechanically ventilated).(1C)Use a fluid challenge technique while associated with a haemodynamic improvement.(1D)R.Phillip Dellinger et al.Crit Care Med.2008;36(1):296-327.11 2022-12-4Fluid ther
5、apy Give fluid challenges of 1000 ml of crystalloids or 300500 ml of colloids over 30min.More rapid and larger volumes may be required in sepsis-induced tissue hypoperfusion.(1D)Rate of fluid administration should be reduced if cardiac filling pressures increase without concurrent hemodynamic improv
6、ement.(1D)R.Phillip Dellinger et al.Crit Care Med.2008;36(1):296-327.12 2022-12-4Levy MM et al.Intensive Care Med.2010;36(2):222-31.13 2022-12-4Sepsis Resuscitation Bundle(first 6hrs)1.Serum lactate measured.2.Blood cultures obtained prior to antibiotic administration.3.From the time of presentation
7、,broad-spectrum antibiotics administered within 3 hours for ED admissions and 1 hour for non-ED ICU admissions.Levy MM et al.Intensive Care Med.2010;36(2):222-31.14 2022-12-4Sepsis Resuscitation Bundle(first 6hrs)4.In the event of hypotension and/or lactate 4 mmol/L(36 mg/dl):a)Deliver an initial mi
8、nimum of 20 ml/kg of crystalloid(or colloid equivalent).b)Apply vasopressors for hypotension not responding to initial fluid resuscitation to maintain mean arterial pressure(MAP)65 mm Hg.Levy MM et al.Intensive Care Med.2010;36(2):222-31.15 2022-12-4Sepsis Resuscitation Bundle(first 6hrs)5.In the ev
9、ent of persistent hypotension despite fluid resuscitation(septic shock)and/or lactate 4 mmol/L(36 mg/dl):a)Achieve central venous pressure(CVP)of 8 mm Hg.b)Achieve central venous oxygen saturation(ScvO2)of 70%.*Levy MM et al.Intensive Care Med.2010;36(2):222-31.16 2022-12-4 1.Low-dose steroids admin
10、istered for septic shock in accordance with a standardized hospital policy.2.Drotrecogin alfa(activated)administered in accordance with a standardized hospital policy.Sepsis Management Bundle(first 24hrs)Levy MM et al.Intensive Care Med.2010;36(2):222-31.17 2022-12-4 3.Glucose control maintained low
11、er limit of normal,but 150 mg/dl(8.3 mmol/L).4.Inspiratory plateau pressures maintained 30 cm H2O for mechanically ventilated patients.Sepsis Management Bundle(first 24hrs)Levy MM et al.Intensive Care Med.2010;36(2):222-31.18 2022-12-4Main results Data from 15,022 subjects at 165 sites were analyzed
12、 to determine the compliance with bundle targets and association with hospital mortality.Levy MM et al.Intensive Care Med.2010;36(2):222-31.19 2022-12-4Main results Compliance with the entire resuscitation bundle increased linearly from 10.9%in the first site quarter to 31.3%by the end of 2 years(P
13、0.4 in patients with severe sepsis or risk of acute kidney injury and suggest not to use 6%HES 130/0.4 or gelatin in these populations.Reinhart K et al.Intensive Care Med.2012;38(3):368-83.45 2022-12-4Recommendations and conclusions We recommend not to use colloids in patients with head injury and n
14、ot to administer gelatins and HES in organ donors.Reinhart K et al.Intensive Care Med.2012;38(3):368-83.46 2022-12-4Recommendations and conclusions We suggest not to use hyperoncotic solutions for fluid resuscitation.Until the results of the ongoing studies(ESM)become available and in the absence of
15、 other RCTs comparing the use of hyperoncotic albumin with other fluid for shock resuscitation,the safety of hyperoncotic albumin remains unclear for the correction of hypoalbuminaemia and for resuscitation in shock.Reinhart K et al.Intensive Care Med.2012;38(3):368-83.47 2022-12-4Recommendations an
16、d conclusions We conclude and recommend that any new colloid should be introduced into clinical practice only after its patient-important safety parameters are establishedReinhart K et al.Intensive Care Med.2012;38(3):368-83.48 2022-12-4Brochard L et al.Am J Respir Crit Care Med.2010;181(10):1128-55
17、.49 2022-12-4Panel recommendations We consider fluid resuscitation with crystalloids to be as effective and safe as fluid resuscitation with hypooncotic colloids(gelatins and 4%albumin).Based on current knowledge,we recommend that hyperoncotic solutions(dextrans,hydroxyethylstarches,or 20-25%albumin
18、)not be used for routine fluid resuscitation because they carry a risk for renal dysfunction.Brochard L et al.Am J Respir Crit Care Med.2010;181(10):1128-55.50 2022-12-4 Decreased glomerular filtration pressure due to increased intracapillary oncotic pressure and(direct)colloid nephrotoxicity(osmoti
19、c nephrosis)are the two purported mechanisms responsible for the higher incidence of renal dysfunction with hyperoncotic colloids than with crystalloids or hypooncotic colloids.Brochard L et al.Am J Respir Crit Care Med.2010;181(10):1128-55.51 2022-12-4 In addition,many adverse effects have been des
展开阅读全文